Anti-PD-L1 Therapy in Oncology: Mechanisms, Clinical Applications, and 2026 Therapeutic Standards
Anti-PD-L1 therapy is a transformative class of cancer immunotherapy that works by blocking the Programmed Death-Ligand 1 (PD-L1) protein on tumor cel...